|
Originally published In Press as doi:10.1074/jbc.M106913200 on August 14, 2001
J. Biol. Chem., Vol. 276, Issue 42, 39492-39500, October 19, 2001
The Hemophilus influenzae Hap Autotransporter Is
a Chymotrypsin Clan Serine Protease and Undergoes
Autoproteolysis via an Intermolecular Mechanism*
Doran L.
Fink §,
Leslie D.
Cope¶ ,
Eric J.
Hansen¶, and
Joseph W. St.
Geme III §**
From The Edward Mallinckrodt Department of Pediatrics
and § Department of Molecular Microbiology, Washington
University School of Medicine, St. Louis, Missouri 63110 and the
¶ Department of Microbiology, University of Texas Southwestern
Medical Center, Dallas, Texas 75235-9048
Received for publication, July 23, 2001, and in revised form, August 7, 2001
 |
ABSTRACT |
The Hemophilus influenzae Hap adhesin
is an autotransporter protein that undergoes an autoproteolytic
cleavage event resulting in extracellular release of the adhesin domain
(Haps) from the membrane-associated translocator domain
(Hap ). Hap autoproteolysis is mediated by
Ser243 and occurs at LN1036-7 and to a lesser extent
at more COOH-terminal alternate sites. In the present study, we sought
to further define the mechanism of Hap autoproteolysis. Site-directed
mutagenesis of residues His98 and Asp140
identified a catalytic triad conserved among a subfamily of
autotransporters and reminiscent of the SA (chymotrypsin) clan of
serine proteases. Amino-terminal amino acid sequencing of
histidine-tagged Hap species and site-directed
mutagenesis established that autoproteolysis occurs at LT1046-7,
FA1077-8, and FS1067-8, revealing a consensus target sequence for
cleavage that consists of ((Q/R)(A/S)X(L/F)) at the
P4 through P1 positions. Examination of a recombinant strain co-expressing a Hap derivative lacking all cleavage sites
(Hap 1036-99) and a Hap derivative lacking proteolytic activity
(HapS243A) demonstrated that autoproteolysis occurs by an
intermolecular mechanism. Kinetic analysis of Hap autoproteolysis in
bacteria expressing Hap under control of an inducible promoter
demonstrated that autoproteolysis increases as the density of Hap
precursor in the outer membrane increases, confirming intermolecular
cleavage and suggesting a novel mechanism for regulation of bacterial
adherence and microcolony formation.
 |
INTRODUCTION |
Bacterial organisms have evolved a number of pathways for
presenting proteins on the cell surface and releasing proteins
extracellularly. In pathogenic organisms, these pathways are essential
for specific interactions that result in colonization of the host and
progression to disease. The bacterial proteins that participate in
these interactions are considered virulence factors and influence
adherence to host cells, damage to host tissues, and interference
with host defense mechanisms.
In Gram-negative bacteria, surface and extracellular proteins must be
transported across the inner membrane, the periplasm, and the outer
membrane. This goal is achieved by one of five distinct secretion
systems. The type V secretion system is used exclusively by the
autotransporter family of proteins, typified by the IgA1 proteases of
Neisseria and Hemophilus species, the first such proteins to be identified (1). Autotransporters are typically expressed
as precursor polypeptides with at least three functional domains,
including an NH2-terminal signal sequence, an internal passenger domain, and a COOH-terminal translocator domain. The signal
sequence directs export of the polypeptide across the bacterial inner
membrane and is then removed by signal peptidase. Subsequently, the
translocator domain inserts into the outer membrane and appears to fold
into a -barrel structure with a central hydrophilic pore, allowing
extrusion of the passenger domain across the membrane. Once the
passenger domain is localized on the cell surface, one of several fates
is possible. In some cases, the passenger domain remains covalently
linked to the membrane-associated -barrel domain. In other cases, it
is cleaved but remains cell associated. In still others, it is cleaved
and then released extracellularly. Cleavage may involve an
autoproteolytic event directed by protease activity in the passenger
domain itself or may occur through the action of a separate bacterial
protease. Autotransporter passenger domains have been ascribed a wide
variety of functions, examples of which include adhesins, toxins,
degradative enzymes, and serum resistance factors (2).
Hemophilus influenzae is a Gram-negative bacterium and
represents a common cause of human disease, including both localized respiratory tract and systemic (invasive) disease (3). The pathogenesis
of H. influenzae disease begins with colonization of the
upper respiratory tract. To facilitate colonization, H. influenzae elaborates both pilus and non-pilus proteins called adhesins, which promote adherence to host epithelial cells by interacting with specific host cell surface molecules. The H. influenzae Hap protein is a non-pilus adhesin that promotes
adherence and invasion in assays with cultured human epithelial cells
and also mediates bacterial aggregation and microcolony formation (4,
5). In recent work, we demonstrated that Hap is an autotransporter protein and consists of a 110-kDa passenger domain called
Haps and a 45-kDa translocator domain called
Hap . The passenger domain has serine protease activity
and directs autoproteolytic cleavage via Ser243, releasing
Haps into the culture supernatant and leaving
Hap embedded in the outer membrane (6). Of note,
Ser243 is part of a GDSGS motif that is present
in a subfamily of autotransporter proteins, including the
Neisseria and Hemophilus IgA1 proteases and a
diverse group of serine protease autotransporters secreted by members
of the Enterobacteriaceae (SPATEs) (7-13). Hap
autoproteolytic cleavage occurs primarily at the peptide bond between
Leu1036 and Asn1037, and mutation of these two
residues results in nearly complete inhibition of cleavage at this site
and increased cleavage at three more COOH-terminal alternate sites (6).
Autoproteolysis is blocked by several serine protease-specific
inhibitors, including phenylmethylsulfonyl fluoride, Pefabloc,
and secretory leukocyte protease inhibitor, a component of human
respiratory tract secretions.
In addition to harboring serine protease activity, the Haps
passenger domain possesses the adhesive activities responsible for
bacterial interaction with epithelial cells and bacterial aggregation.
Thus, at first glance release of this domain from the bacterial cell
surface seems counterproductive to promoting successful colonization.
Indeed, mutation of the Hap active site serine to an alanine results in
complete inhibition of autoproteolytic processing, full retention of
Haps on the cell surface, and increased adherence and
aggregation (6). On the other hand, release of Haps may
benefit H. influenzae in ways unrelated to its adhesive activities. For example, activity against host substrates has been
demonstrated for IgA1 protease as well as several of the SPATE family
members (2, 7, 14, 15). Although no such host substrate has been
identified yet for Hap, it is possible that Hap proteolytic activity
against epithelial tissue components or immune system effectors may
facilitate initial colonization. Alternatively, autoproteolytic
cleavage of Hap at several sites on the same molecule may release
bioactive peptides, as has been documented for IgA1 protease (16).
Finally, shedding of an adhesive domain from the cell surface may
facilitate disbursement of individual organisms from microcolonies and
allow spread to new sites. Such events may be controlled by the
presence of host factors that modulate Hap autoproteolytic activity
(e.g. secretory leukocyte protease inhibitor) or by features
inherent to the mechanism of autoproteolysis itself.
In the present study, we sought to characterize Hap autoproteolysis
more fully, including the mechanism of catalysis, the identities of all
cleavage sites, and the molecular nature of the enzyme-substrate
interaction. Our results demonstrate that Hap belongs to the SA
(chymotrypsin) clan and contains a catalytic triad conserved among a
subfamily of autotransporter serine proteases. Identification of the
three alternate autoproteolytic cleavage sites in Hap revealed a
consensus target sequence for Hap enzymatic activity. Interestingly,
kinetic analysis and examination of a recombinant strain expressing two
different derivatives of Hap established that autoproteolysis occurs at
least in part via an intermolecular mechanism. These results provide
insights into an expanding family of bacterial serine proteases and
suggest a novel mechanism for regulation of bacterial adherence.
 |
EXPERIMENTAL PROCEDURES |
Protein Sequence Alignments--
Amino acid alignments of
protein sequences were performed using ClustalW v1.8 software available
on the Baylor College of Medicine Human Genome Sequencing Center
website (dot.imgen.bcm.tmc.edu).
Bacterial Strains and Plasmids--
The bacterial strains and
plasmids used in this study are listed in Table
I (4, 6, 17, 18, 20, 26).
H. influenzae strains were grown as described previously
(21) and were stored at 80 °C in brain-heart infusion broth with
20% glycerol. Escherichia coli strain DH5 was grown on
Luria-Bertani (LB) agar or in LB broth. E. coli strains
were stored at 80 °C in LB broth with 50% glycerol. Antibiotic
concentrations for H. influenzae included the following:
tetracycline, 5 µg/ml; kanamycin, 50 µg/ml; chloramphenicol, 1 µg/ml; and streptomycin, 250 µg/ml. Antibiotic concentrations for
E. coli included tetracycline, 12.5 µg/ml,
kanamycin, 50 µg/ml, and ampicillin, 100 µg/ml.
Recombinant DNA Methods--
DNA ligations, restriction
endonuclease digestions, and gel electrophoresis were performed
according to standard techniques (22). Plasmids were introduced into
E. coli strain DH5 by chemical transformation (22).
H. influenzae strain DB117 was transformed using the MIV
method of Herriott et al. (23).
Construction of Plasmids Encoding Mutated Hap
Derivatives--
Site-directed mutagenesis was performed using
recombinant PCR1 techniques.
To construct pHapH98A, pHapH117A, pHapD139A, and pHapD140A, pMLD100
(pUC19 containing a 6.7-kb insert with the hap gene from
H. influenzae strain N187) was used as a template to amplify
a 1.4-kb 5' PCR fragment and a 0.9-kb 3' PCR fragment that overlapped
at an 18-base region encompassing the appropriate mutated site. Each 5'
fragment was then combined with the corresponding 3' fragment in a 1:1
molar ratio to serve as template in generating a 2.3-kb mutated
recombinant PCR fragment using external primers from the initial PCR
reactions plus a 1:100 dilution of an internal primer corresponding to
the coding sequence of the mutated site. These recombinant PCR
fragments were digested with AvaI and ClaI and
then ligated into AvaI-ClaI-digested pMLD100.
For construction of the primary autoproteolytic cleavage site mutant
pHapL1036S, initial PCR products (1.1 kb 5' fragment and 1.2 kb 3'
fragment) were amplified from pMLD100 and used as templates to generate
a 2.3-kb mutated recombinant PCR fragment as described above. This
recombinant PCR fragment was then digested with NheI and
HindIII and ligated into
NheI-HindIII-digested pMLD100. The double
autoproteolytic cleavage site mutants pHapL1036S::L1046S, pHapL1036S::F1067S, and pHapL1036S::F1077S were
constructed in the same manner using pMLD100::HapL1036S as
the template in the initial PCR reactions.
To construct plasmid pHapLN1036-7SG::G3H6, a 1.8-kb PCR
fragment corresponding to the COOH-terminal 600 residues of Hap was amplified from pDH101 (like pMLD100, but with the hap gene
insert in the opposite orientation), incorporating codons for 3 glycine residues, 6 histidine residues, and a BamHI site at the 3'
end of the hap gene (5' end of the PCR product). This PCR
fragment was digested with BamHI and NheI and
ligated into BamHI-NheI-digested pDH101. The
resulting plasmid, pDH101::G3H6, was digested with DsaI and NsiI, liberating a 6.3-kb fragment that
was then replaced by ligation with a 6.3-kb insert excised from
DsaI-NsiI-digested pDH101::LN1036-7SG
(6).
Construction of pHap 1036-99 was carried out by first amplifying
initial PCR fragments corresponding to residues 650-1035 (1.1-kb 5'
fragment) and 1100-1395 (1.1-kb 3' fragment) of Hap. The primers used
to create these PCR products were engineered such that the two
fragments overlapped at an 18-base region, allowing amplification of a
recombinant PCR product in which the codons for residues 1035 and 1100 were immediately juxtaposed, deleting the intervening sequence. This
recombinant PCR fragment was digested with NheI and
HindIII and ligated into
NheI-HindIII-digested pMLD100.
Plasmid pJS106::Trc was constructed by first amplifying a
1.6-kb PCR fragment that contained the lacIq
gene, trc promoter, and polylinker cloning region from
pTrc99A. The primers used in this amplification were engineered such
that the resulting PCR product contained HindIII and
PstI sites at the 5' end and a HindIII site at
the 3' end, allowing digestion of this fragment with HindIII
and ligation into HindIII-digested pDH101. The resulting
plasmid, pDH101::Trc, was then digested with NcoI
and BglII, excising a fragment containing the pTrc99A polylinker cloning region, the hap upstream region, and 1.4 kb of the hap coding sequence. Next, a 1.4-kb PCR fragment
corresponding to the excised hap coding sequence was
amplified from pDH101, incorporating an NcoI site at the 5'
end. This fragment was digested with NcoI and
BglII and ligated into
NcoI-BglII-digested pDH101::Trc, thereby juxtaposing the hap start codon downstream of the
trc promoter and ribosome-binding site.
Following the introduction of mutated fragments into the
complete hap gene, mutations were verified by nucleotide
sequencing. Subsequently, the mutated hap genes were excised
as 6.7-kb PstI fragments and then ligated into
PstI-digested pGJB103. Exceptions included the mutated
hap gene encoding Hap 1036-99, which was ligated into
PstI-digested pLS88, and the mutated hap gene
encoding HapLN1036-7SG::G3H6, which was excised as a
BamHI-PstI fragment and ligated into
BglII-PstI-digested pGJB103. All constructs were first transformed into E. coli DH5 and then into H. influenzae strain DB117.
Analysis of Bacterial Culture Supernatant and Outer Membrane
Fractions--
DB117 expressing wild type Hap or mutant derivatives
was grown to an optical density at 600 nm (A600)
of 0.8. Sarkosyl-insoluble outer membrane proteins were isolated by the
method of Carlone et al. (24), and extracellular proteins
were precipitated from culture supernatants with 10% trichloroacetic
acid as described previously (4). Outer membrane fractions were
resuspended in 25 µl of 10 mM HEPES, pH 7.4, plus 25 µl
of 2 × Laemmli buffer, while precipitated extracellular proteins
were resuspended in 10 µl of 1 M Tris, pH 9.0, plus 10 µl of 2 × Laemmli buffer. Protein samples were resolved by
SDS-PAGE using 7.5% SDS-polyacrylamide gels (25). To ensure that
comparable amounts of protein were analyzed, similar volumes from
cultures of similar density were loaded into each lane. Resolved
proteins were electrotransferred to a nitrocellulose membrane and then
detected by immunoblot analysis using antiserum Rab730 diluted 1:500
(6). An anti-rabbit IgG antiserum conjugated to horseradish peroxidase
(Sigma) was used as the secondary antibody, and detection of antibody
binding was accomplished by incubation of the membrane in a
chemiluminescent substrate solution (Pierce) and exposure to film.
Kinetic Analysis of Autoproteolysis during Induced Expression of
Hap--
DB117 expressing Hap under the control of a IPTG-inducible
promoter (DB117/pJS106::Trc) was grown to an
A600 of 1.0, at which time IPTG was added to a
final concentration of 0.1 mM. A 10-ml aliquot was removed
from the culture every 10 min, beginning with the addition of IPTG, and
proteins were isolated from the culture supernatants and outer membrane
fractions as described above. In order to compensate for any
differences in protein amounts caused by increases in culture density
over the course of the experiment or by variations in purification
efficiency, volumes loaded for resolution by SDS-PAGE were adjusted
according to culture density for secreted proteins and according to
final protein concentration (Bio-Rad protein assay) for outer membrane
proteins. After resolution by SDS-PAGE, transfer to nitrocellulose, and
detection by immunoblotting, protein band intensities were quantitated
by scanning densitometry using an LKB Ultroscan XL laser densitometer
(Bromo, Sweden). To further ensure that protein from an equivalent
number of bacterial cells had been loaded in each lane, levels of major
outer membrane protein P4 (OMP P4) in each of the outer membrane
fractions were quantified by scanning densitometry after detection by
an anti-P4 monoclonal antibody, EPR5-2.1 (generously provided by B. Green, Wyeth-Lederle Vaccines), and anti-mouse IgG secondary antiserum conjugated to horseradish peroxidase (Sigma).
Inactivation of ompP2, ompP5, and rec1 in Strain Rd--
To
inactivate the ompP2 gene in H. influenzae strain
Rd, the cat cartridge from plasmid pUC ECAT was inserted
into a PvuII site contained within the ompP2 gene
from type b strain DL42 on plasmid pEJH91-1-35 L3 (26). The inactivated
ompP2 gene was excised by digestion with PstI,
purified by agarose gel electrophoresis, and used to transform strain
Rd. To inactivate the ompP5 gene in Rd/ompP2, a
1.5-kb PCR fragment encoding the 3' half of the Rd ompP5
gene plus 1 kb of downstream sequence was amplified from Rd chromosomal
DNA, incorporating DraIII sites at each end to facilitate
ligation of the fragment into DraIII-digested pUC4K (Amersham Pharmacia Biotech). The resulting 5.6-kb plasmid was then
digested with PstI, excising a 2.8-kb fragment containing the kanamycin resistance cassette from pUC4K followed by the cloned portion of ompP2 and downstream sequence. This 2.8-kb
fragment was then ligated into PstI-digested pUC19 (New
England Biolabs), creating plasmid
pUC19::kanR-P5-3'. A 1.5-kb PCR fragment encoding
the 5'-half of the Rd ompP5 gene plus 1 kb of upstream
sequence was amplified from Rd chromosomal DNA, incorporating an
EcoRI site at the 5' end and an XbaI site at the
3' end to facilitate ligation of the fragment into
EcoRI-XbaI-digested pUC19::
kanR-P5-3'. The resulting 5.9-kb plasmid,
pUC19::P5-5'-kanR-P5-3', was linearized by
digestion with XmnI and used to transform Rd/ompP2. Finally, the rec1 gene of
Rd/ompP2/ompP5 was inactivated by transformation
with DNA from strain BC200/rec1, which possesses a mutant
rec1 gene linked to streptomycin resistance (27).
Streptomycin-resistant transformants were screened for the loss of
recombination activity by assaying their ability to survive exposure to
44 ergs/cm2 of ultraviolet radiation at 254 nm.
Identification of Hap Autoproteolytic Cleavage
Sites--
Plasmid pHapLN1036-7SG::G3H6 was transformed
into strain Rd/ompP2/ompP5/rec1. A
1-liter culture of
Rd/ompP2/ompP5/rec1/pHapLN1036-7SG::G3H6 was grown to an A600 of 0.8, and
Sarkosyl-insoluble outer membrane proteins were purified using a
scaled-up version of the protocol described by Carlone et
al. (24). The pellet consisting of the outer membrane fraction was
resuspended in 5 ml of 20 mM Tris, 6 M
guanidinium chloride, 100 mM sodium chloride, pH 8.0. 1 ml of a 50% slurry of Talon beads (CLONTECH) was
added to the sample, and the mixture was incubated at 4 °C for
3 h. The Talon beads were then washed 4 times with 5 ml of 20 mM Tris, 8 M urea, 100 mM sodium
chloride, 10 mM imidazole, pH 8.0, and histidine-tagged outer membrane proteins were eluted from the beads in 0.5 ml of 20 mM Tris, 8 M urea, 100 mM sodium
chloride, 10 mM imidazole, 100 mM EDTA, pH 8.0. The eluted proteins were resolved by SDS-PAGE using 7.5%
SDS-polyacrylamide gels and electrotransferred to a polyvinylidene
difluoride membrane (28). After staining with Coomassie Brilliant Blue
R-250, three protein bands migrating at 43, 41, and 39 kDa,
respectively, were excised from the membrane and submitted to Midwest
Analytical (St. Louis, MO) for amino-terminal sequence determination
performed by automated Edman degradation using a Perkin-Elmer Applied
Biosystems model 477A sequencing system.
 |
RESULTS |
The Hap Catalytic Triad Consists of His98,
Asp140, and Ser243--
In considering the
mechanism of Hap autoproteolysis, we first sought to identify the
residues that participate with Ser243 in the Hap catalytic
site. Examination of the Hap predicted amino acid sequence revealed two
aspartic acid residues ~100 residues amino-terminal to
Ser243 (Asp139 and Asp140) and two
histidine residues 120-140 residues amino-terminal to Ser243 (His98 and His117),
reminiscent of the SA (chymotrypsin) clan of serine proteases. Alignment of Hap sequences from eight different clinical isolates of
nontypable H. influenzae revealed absolute conservation of all four of these residues (data not shown). With this information in
mind, we changed each of these residues individually to an alanine
using site-directed mutagenesis and then expressed the resulting mutant
proteins in H. influenzae strain DB117. As shown in Fig.
1, examination of outer membrane proteins
from DB117/pHapD140A and DB117/pHapH98A demonstrated accumulation of
the 155-kDa full-length Hap protein and absence of the 39-45-kDa
Hap cleavage products, identical to earlier observations
with DB117/pHapS243A. Similarly, examination of proteins in culture
supernatants from these two strains demonstrated the absence of the
110-kDa secreted Haps protein (Fig. 1). In contrast,
mutation of either Asp139 or His117 had no
effect on autoproteolysis. Taken together, these data suggest that the
Hap catalytic triad is composed of Ser243,
Asp140, and His98. Alternatively, mutation of
these residues may have affected autoproteolysis by disrupting the
tertiary structure around the active site. An amino acid alignment of
10 autotransporter serine proteases that share the GDSGS
sequence surrounding the putative active site serine revealed absolute
conservation of all three of these residues (Fig.
2), providing further evidence that these amino acids represent the catalytic triad.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of mutations of Hap catalytic triad
residues on the processing and secretion of Haps.
Shown is an analysis of outer membrane proteins (lanes 1-6)
and culture supernatants (lanes 7-12) from
late-exponential phase cultures of DB117/pJS106 (containing wild type
Hap), DB117/pHapS243A, DB117/pHapD139A, DB117/pHapD140A,
DB117/pHapH117A, and DB117/pHapH98A. Proteins were assessed by
immunoblot using antiserum Rab730, which reacts with full-length Hap,
Haps, and Hap . The lanes of the gel were
loaded as follows: lanes 1 and 7, DB117/pJS106;
lanes 2 and 8, DB117/pHapS243A; lanes
3 and 9, DB117/pHapD139A; lanes 4 and
10, DB117/pHapD140A; lanes 5 and 11,
DB117/pHapH117A; lanes 6 and 12, DB117/pHapH98A.
Dots indicate the 155-kDa full-length Hap protein and the
45-kDa Hap preferred cleavage product. The
arrow indicates the 110-kDa Haps secreted
protein.
|
|

View larger version (101K):
[in this window]
[in a new window]
|
Fig. 2.
Amino acid sequence alignment of the
amino-terminal portions of autotransporters from diverse pathogenic
bacterial species. The amino acid sequences of 10 autotransporters
were aligned using ClustalW v.1.8. Absolutely conserved residues are
highlighted by a dark gray background and white
lettering, and blocks of similar residues are highlighted in
light gray. The conserved serine (Ser243),
aspartate (Asp140), and histidine (His98)
residues involved in the Hap catalytic triad are shown in white
lettering and marked with an asterisk. Abbreviations
used: IgA1-pro, IgA1 protease; H. inf, H. influenzae; N. men, N. meningitidis;
S. flex, S. flexneri.
|
|
The P1 Residue Is Critical for Recognition of the Hap Primary
Autoproteolytic Cleavage Site--
Previous studies demonstrated that
site-directed mutagenesis of Hap residues Leu1036 and
Asn1037 virtually eliminated autoproteolytic cleavage of
the LN1036-7 peptide bond and resulted in increased abundance of three
bands, 39-43 kDa in size, in immunoblots of outer membrane proteins
from bacteria expressing this Hap derivative, representing cleavage at
more COOH-terminal alternate sites. Given that serine protease enzymatic activity typically relies on recognition of residues immediately NH2-terminal to the cleaved peptide bond, we
sought to determine whether mutation of the P1 residue alone would
inhibit Hap autoproteolysis at the LN1036-7 site. As shown in Fig.
3A, examination of outer
membrane proteins from DB117/HapL1036S revealed a marked decrease in
abundance of the 45-kDa Hap species, indicating nearly
complete elimination of cleavage at the LN1036-7 site. At the same
time, the 110-116-kDa secreted Haps proteins were present
in slightly decreased quantity in culture supernatants (Fig.
3B). In this and other immunoblots, the Haps
proteins resulting from autoproteolytic processing at multiple sites
appeared to migrate as a single band due to their close proximity in
size. A very small amount of the 45-kDa cleavage product was produced, similar to the situation with HapLN1036-7SG, suggesting that additional amino acids beyond the P1 residue may also be critical for target site
recognition.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of mutations of Hap autoproteolytic
cleavage site P1 residues on the processing and secretion of
Haps. Panel A, outer membrane proteins from
late-exponential phase cultures of DB117/pJS106 (containing
wild-type Hap), DB117/pHapL1036S, DB117/pHapL1036S::L1046S,
DB117/pHapL1036S::F1067S, and
DB117/pHapL1036S::F1077S. Panel B,
extracellular proteins from the same strains. Proteins were assessed by
immunoblot using antiserum Rab730, which reacts with full-length Hap,
Haps, and Hap . The gels in both panels were
loaded as follows: lane 1, DB117/pJS106; lane 2,
DB117/pHapL1036S; lane 3,
DB117/pHapL1036S::L1046S; lane 4,
DB117/pHapL1036S::F1067S; lane 5,
DB117/pHapL1036S::F1077S. The arrow indicates the
155-kDa full-length Hap protein. The dot indicates the
45-kDa Hap species resulting from cleavage at the
preferred site. The asterisks indicate the 39-43-kDa
Hap species resulting from cleavage at alternate
sites.
|
|
Identification of Alternative Hap Autoproteolytic Cleavage Sites
Reveals a Conserved Motif--
Next we set out to identify the
alternate cleavage sites responsible for production of the 39-43-kDa
Hap minor cleavage products. To facilitate recovery of
these proteins for NH2-terminal amino acid sequencing, we
first constructed a Hap derivative that contains both the mutated
primary cleavage site (LN1036-7SG) and a 3xGly-6xHis tag at the C
terminus. Ultimately this derivative was expressed in an H. influenzae strain Rd mutant that does not express major outer
membrane proteins P2 and P5, which consistently contaminated early
preparations of His-tagged Hap minor cleavage products
from strain DB117. Talon bead affinity purification of 6xHis-tagged
proteins from the outer membrane of
Rd/ompP2/ompP5/rec1/pHapLN1036-7SG::G3H6 lead to the recovery of three protein species migrating at 43, 39, and
41 kDa, in order of abundance (not shown). NH2-terminal amino acid sequencing of the 43-kDa band revealed the presence of
equivalent amounts of two proteins, one beginning with
Thr1047 (TAETQK) and the other beginning with
Ala1048 (AETQKS), indicating that autoproteolytic cleavage
at the secondary site occurs either between Leu1046 and
Thr1047, between Thr1047 and
Ala1048, or both. NH2-terminal amino acid
sequencing of the 39- and 41-kDa bands resulted in unambiguous
assignment of the tertiary site between Phe1077 and
Ala1078 (ALEAAL) and the quaternary site between
Phe1067 and Ser1068 (SDPLLP). Alignment of the
five residues flanking each side of the primary, secondary, tertiary,
and quaternary autoproteolytic cleavage sites allowed construction of a
consensus target sequence for Hap enzymatic activity, namely
((Q/R)(S/A)X(L/F)) at the P4 through P1 positions (Fig.
4). There is no apparent similarity of
sequence at the P' positions.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
Alignment of sequences surrounding the four
HapN187 autoproteolytic cleavage sites. The peptide
bond where cleavage occurs is indicated by the vertical
line. The numbered positions in the Hap amino acid sequence of the
P1 and P1' residues on either side of the cleaved bond are indicated in
parentheses.
|
|
To confirm the conclusions resulting from
NH2-terminal amino acid sequencing of the His-tagged
Hap species and to assess whether the P1 residue is
critical for recognition of the alternate cleavage sites, we performed
site-directed mutagenesis. As shown in Fig. 3, mutation of the P1
residues at both the primary and secondary sites (HapL1036S, L1046S)
resulted in nearly complete elimination of both the 45- and 43-kDa
cleavage products and a corresponding decrease in abundance of the
110-116 kDa secreted Haps proteins. The finding that
mutation of Leu1046 disrupted cleavage at the secondary
site suggests that this site probably occurs between
Leu1046 and Thr1047, although it is also
possible that Leu1046 is important as the P2 residue for
cleavage between Thr1047 and Ala1048. Unlike
the situation with mutation of the primary site alone, mutation of both
the primary and secondary sites did not result in increased abundance
of tertiary and quaternary cleavage products. Mutation of the P1
residues at both the primary and tertiary sites (HapL1036S, F1077S)
resulted in elimination of the 45- and 39-kDa cleavage products, while
mutation of the P1 residues at both the primary and quaternary sites
(HapL1036S, F1067S) resulted in elimination of the 45- and 41-kDa
cleavage products (Fig. 3A). The amounts of 110-116-kDa
secreted Haps proteins in culture supernatants from DB117
expressing these two mutants were not appreciably different from what
was observed for DB117/pHapL1036S (Fig. 3B), further demonstrating that cleavage at the tertiary and quaternary sites contributes little to Hap autoproteolysis, even in the context of the
primary site mutant.
Hap Autoproteolysis Occurs via an Intermolecular Mechanism--
In
considering the mechanism of Hap autoproteolysis, it is possible that a
given molecule cleaves itself. Alternatively, one Hap molecule may
cleave an adjacent neighboring molecule. To address the possibility
that intermolecular cleavage occurs, we simultaneously expressed two
Hap derivatives in the same bacterial cell. The first derivative,
HapS243A, lacks proteolytic activity and therefore is unable to mediate
autoproteolytic release of the Haps passenger domain when
expressed by itself (Fig. 5, A
and B). The second derivative, Hap 1036-99, is
proteolytically active but lacks a 64-residue region containing all
four autoproteolytic cleavage sites, thus eliminating autoproteolysis
when expressed on its own (Fig. 5, A and B). When
these two derivatives were expressed together on the same bacterial
cell surface, we observed four 39-45-kDa Hap species in
the outer membrane and 110-116-kDa Haps species in culture
supernatants, representing cleavage of Haps from
Hap at all four sites (Fig. 5, A and
5). These results demonstrate that proteolytically active
Hap 1036-99 molecules were recognizing and acting on cleavage sites
in nearby HapS243A molecules. Examination of fractions from a
co-culture prepared with both DB117/HapS243A and DB117/Hap 1036-99
revealed no Hap in outer membranes and no
Haps in the culture supernatant, suggesting that
intermolecular autoproteolysis likely occurs only between Hap molecules
on the same bacterial cell and not between Hap molecules on different
cells (not shown).

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 5.
Examination of Haps processing
and secretion by forced intermolecular autoproteolysis.
Panel A, outer membrane proteins from late-exponential phase
cultures of DB117/pHapS243A, DB117/pHap 1036-99, DB117/pJS106
(containing wild-type Hap), and DB117/pHapS243A/pHap 1036-99.
Panel B, extracellular proteins from the same strains.
Proteins were assessed by immunoblot using antiserum Rab730, which
reacts with full-length Hap, Haps, and Hap .
The gels in both panels were loaded as follows: lane 1,
DB117/pHapS243A; lane 2, DB117/pHap 1036-99; lane
3, DB117/pJS106; lane 4,
DB117/pHapS243A/pHap 1036-99. The arrows indicate the
155-kDa full-length Hap protein and the 148-kDa Hap derivative
lacking the intervening region between Haps and
Hap . The dot indicates the 45-kDa
Hap species resulting from cleavage at the preferred
site. The asterisks indicate the 39-43-kDa
Hap species resulting from cleavage at alternate
sites.
|
|
To extend the observation that intermolecular cleavage occurs, we
examined the possibility that released Haps is capable of cleaving the full-length Hap precursor on the cell surface. Consistent with previous results, we found that incubation of purified
Haps (final concentration 2 µg/ml) with DB117/HapS243A
resulted in cleavage of HapS243 at the primary site (Fig.
6) (6). However, comparison with outer
membrane fractions from DB117 expressing wild type Hap revealed
relatively reduced cleavage at the primary site (reduced amount of the
45-kDa Hap protein) and no cleavage at the 3 alternate
sites (no smaller Hap species) (Fig. 6). Next, we
incubated purified Haps with DB117 expressing a Hap
derivative containing only the -barrel domain (Hap ,
beginning after the primary cleavage site). Again, there was no
evidence of cleavage at the 3 alternate sites (Fig. 6). Given that the
amount of purified Haps used in these digestion experiments
was much greater than the quantity of Haps released into
culture supernatants of DB117 expressing wild-type Hap, it seems
unlikely that intermolecular cleavage by secreted Haps
plays a significant role in the autoproteolytic mechanism.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 6.
Analysis of Haps-mediated
proteolysis. Shown is an analysis of outer membrane proteins from
DB117/pJS106 (containing wild-type Hap), DB117/pHapS243A, and
DB117/pHap (containing the Hap signal sequence fused
in-frame to the Hap -barrel domain) after incubation
with purified Haps or phosphate-buffered saline control.
Proteins were assessed by immunoblot using antiserum Rab730, which
reacts with full-length Hap and Hap . The lanes in the
gel were loaded as follows: lane 1, DB117/pJS106 treated
with phosphate-buffered saline; lane 2, DB117/pHapS243A
treated with phosphate-buffered saline; lane 3,
DB117/pHapS243A treated with 2 µg of Haps; lane
4, DB117/pHap treated with phosphate-buffered
saline; lane 5, DB117/pHap treated with 2 µg of Haps. The arrow indicates the 155-kDa
full-length Hap protein. The dot indicates the 45-kDa
Hap species resulting from cleavage at the preferred
site. The asterisks indicate the 39-43-kDa
Hap species resulting from cleavage at alternate
sites.
|
|
Hap Autoproteolysis Is Dependent on the Density of Hap on the
Bacterial Surface--
Although our experiments assessing cleavage of
HapS243A by Hap 1036-99 demonstrated intermolecular autoproteolysis,
they did not exclude the possibility of an intramolecular mechanism as well. To address the extent to which intermolecular cleavage occurs during processing of wild type Hap, we examined the kinetics of autoproteolysis as a function of the amount of Hap protein present on
the cell surface. Autoproteolysis due to a purely intermolecular mechanism would be predicted to increase as a function of protein density on the bacterial surface, while autoproteolytic cleavage due to
a purely intramolecular mechanism would be expected to occur at a
constant rate independent of protein density. In performing these
studies, we expressed wild type Hap in strain DB117 under control of an
IPTG-inducible promoter. In order to measure the effect of increasing
levels of Hap expression on the rate of autoproteolytic cleavage, we
quantitated Haps in culture supernatants and Hap precursor
and Hap in outer membrane fractions. Briefly, bacteria were grown to early stationary phase, and then IPTG was added to the
culture medium to induce maximal expression of Hap. Samples were
collected every 10 min over the next 70 min for isolation of culture
supernatant and outer membrane fractions. Equivalent amounts of these
fractions were analyzed by immunoblotting, and quantities of Hap
precursor, Haps, and Hap were determined by
scanning densitometry (Fig.
7A). Values were normalized
based on levels of a constitutively expressed major outer membrane
protein, OMP P4 (data not shown). As shown in Fig. 7B, the
amount of Hap precursor plus Hap present in the outer
membranes increased linearly over time beginning at the point of
induction. Because these two protein species represent the total amount
of Hap on the cell surface (cleaved and uncleaved forms), we concluded
that IPTG induction resulted in a linear increase in Hap expression over time (first-order kinetics). In contrast, Hap and
Haps increased in quantity at exponential rates. Together
these results demonstrate that autoproteolysis of wild type Hap
increases exponentially in response to linear increases in the quantity
of Hap on the cell surface, suggesting that a
density-dependent intermolecular mechanism is the
predominant means of autoproteolysis.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 7.
Examination of the effect of Hap expression
levels on the rate of Hap autoproteolytic processing. Panel
A, analysis of outer membrane proteins (Outer
Membranes, time points 0 to 70 min) and extracellular proteins
(Supernatants, time points 0 to 70 min) from
DB117/pJS106::Trc99 (containing wild-type Hap expressed under
the control of an IPTG-inducible promoter). The culture was grown to
early stationary phase (A600 = 1.0) and then
induced with 0.1 mM IPTG. The lanes in the gel were loaded
with outer membrane proteins or extracellular proteins prepared from a
10-ml sample collected at the indicated time after induction. Proteins
were assessed by immunoblot using antiserum Rab730, which reacts with
full-length Hap, Haps, and Hap . The
arrows indicate the 155-kDa full-length Hap protein and the
45-kDa Hap species resulting from cleavage at the
preferred site. The dot indicates the 110-kDa secreted
Haps protein. Panel B, kinetic analysis of Hap
expression and autoproteolytic processing. The intensities of the
protein bands shown in Panel A were quantified by scanning
densitometry to approximate the amounts of full-length Hap and
Hap present in outer membrane fractions and the amounts
of Haps present in culture supernatants at each time point.
Shown are the detected levels of full-length Hap plus
Hap (diamonds, solid line),
Hap alone (squares, dashed line), and
Haps (circles, dotted line).
|
|
 |
DISCUSSION |
Identification of His98, Asp140, and
Ser243 as a set of three residues involved in the Hap
catalytic site provides strong evidence that Hap is a classical serine
protease with a catalytic triad. The order in which these residues
appear in the Hap primary sequence and the distances between them
suggest that Hap is a member of the SA (chymotrypsin) clan of serine
proteases (29). This clan comprises a diverse spectrum of proteases
including the eukaryotic chymotrypsins, trypsins, and leukocyte
elastase of the S1 family, as well as several other families of
microbial proteases. Members of the SA clan share a conserved catalytic
site and a similar three-dimensional structure.
To extend our conclusion that Hap is a member of the SA clan, we
used the 3D-PSSM structural modeling program (Imperial Cancer Research Fund Fold Recognition Server,
www.bmm.icnet.uk/servers/3dpssm) to predict the secondary structural
elements within the 300-residue Hap NH2-terminal domain and
to compare predicted folding patterns with a library of known protein
structures. The results of this analysis strongly suggest that the Hap
NH2-terminal domain could be modeled to fit the
three-dimensional structure of bovine chymotrypsinogen C, an S1 family
protease with similarities in sequence and structure to both
chymotrypsin and elastase (35). Chymotrypsinogen C and the Hap
NH2-terminal domain exhibit roughly 19% identity at the amino acid level. Importantly, with few exceptions, hydrophobic residues predicted to form the structural core of bovine
chymotrypsinogen C are conserved in the Hap sequence. Our analysis also
predicts that Hap could be modeled using the structure of trypsin from the fungal organism Streptomyces griseus, although
conservation of predicted core residues is not as extensive between Hap
and S. griseus trypsin as it is between Hap and bovine
chymotrypsinogen C (36). Ongoing efforts to crystallize the secreted
Haps protein may eventually confirm these structural predictions.
Further analysis of the Hap amino acid and nucleotide sequences
highlights several features that may help to evaluate the evolutionary
relationship between Hap and other SA clan members. For example, the
AGT codon present at the Hap active site serine is reminiscent of AGY
codons utilized by physiologically complex proteases of higher
metazoans, such as blood clotting factors, and contrasts to the TCN
codons conserved among more "primordial" clan members, such as
typsin, chymotypsin, and elastase (34). Furthermore, whereas most SA
clan proteases have either a proline or tyrosine at position 225 as a
determinant of Na+-activated allostery, Hap has an aspartic
acid at the corresponding position. Other notable differences between
functionally important residues in S1 family proteases and their
counterparts in the Hap sequence include substitutions for conserved
serines at positions 189 and 214 by alanine and arginine, respectively,
and the absence of four cysteine residues at positions 1, 122, 191, and
220 that form disulfide bonds critical to the stability of the
catalytic pocket. These dissimilarities may reflect how selective
pressures contributing to the evolution of Hap differed from those
affecting eukaryotic S1 proteases and further suggest that the Hap
catalytic pocket may represent a distinct and possibly novel structure.
Alignment of the amino acid sequences of Hap and nine other
autotransporter proteases revealed sequence similarities throughout the
NH2-terminal domains and absolute conservation of all three catalytic triad residues, suggesting that these proteins comprise a
subfamily of autotransporter proteases that share a common structure at
the catalytic site. Included in this subgroup are Hap, the Neisseria and Hemophilus IgA1 proteases, and the
SPATEs, a closely related set of putative bacterial virulence factors
with distinct enzymatic functions. The existing classification system
has tentatively assigned these autotransporters to the S6 family within
the SA clan, based solely on conservation of a GDSGS motif and
identification of the active site serine within this motif in three
members of the subfamily (30, 31). Our present study provides the first conclusive biochemical evidence for assignment of an autotransporter to
the SA clan and further suggests that Hap belongs to a subset of
autotransporters related to but distinct from the S1 family proteases.
Of note, several groups have described members of a second family of
autotransporter serine proteases that possess a presumed catalytic
motif seemingly distinct from that of Hap and its family members (32,
33). Based on the conservation of aspartic acid, histidine, and serine
residues among its members in the same order and relative positions as
the active site residues in subtilisin, this second family is referred
to as the subtilases, although biochemical data to support this claim
have not been reported.
Identification of the four Hap autoproteolytic cleavage sites provides
evidence that Hap may be most like chymotrypsins in terms of substrate
specificity. Site-directed mutagenesis confirmed that the residue at
the P1 position of Hap autoproteolytic cleavage sites is critical for
recognition of substrate by the Hap catalytic pocket, a feature typical
of serine proteases in general. Members of the SA clan have differing
substrate specificities at the P1 position, with examples including
bulky hydrophobic residues such as phenylalanine and leucine in
chymotrypsin-like proteases, basic residues such as arginine and lysine
in trypsin-like proteases, and small hydrophobic residues such as
alanine in elastase-like proteases. The presence of either leucine or
phenylalanine at the P1 positions of the Hap autoproteolytic cleavage
sites suggests that the Hap catalytic site substrate pocket can
accommodate bulky hydrophobic residues, analogous to chymotrypsin. The
presence of leucine at the P1 position of the Hap primary and secondary autoproteolytic cleavage sites suggests a preference for this residue
over phenylalanine, contrasting with most chymotrypsin-like proteases
but resembling bovine chymotrypsinogen C, which cleaves preferentially
after leucine residues, presumably due to the influence of a threonine
residue (Thr926) in the specificity pocket (35). Cleavage
after large hydrophobic residues has also been demonstrated for several
other IgA1 protease-like autotransporters. The Neisseria and
Hemophilus IgA1 proteases cleave after proline residues
within the hinge region of IgA1, and in vitro digestion of
chromagenic peptide substrates by SepA from Shigella
flexneri suggested that this enzyme acts on target sites with
phenylalanine at the P1 position (37, 38). Further examination of Hap
substrate specificity using chromogenic peptide substrates should help
to address whether Hap is truly a chymotrypsin-like protease, keeping
in mind that recognition of the cleavage site may require the presence
of additional residues beyond those present in commonly available
substrate reagents. For many SA clan proteases, substrate recognition
and catalytic efficiency are dependent on residues both
NH2-terminal to and COOH-terminal to the P1 position. At
this point it remains unclear whether substrate positions P2 through P4
affect Hap enzymatic activity, although homologies between residues at
the P2 and P4 positions among the autoproteolytic cleavage sites
suggest this possibility.
Intermolecular mechanisms of autoproteolytic processing have been
demonstrated for a number of proteases. Typically, the processing event
serves to remove an inhibitory peptide chain from a zymogen, thus
converting it into an active enzyme (19, 39-42). Autoproteolysis of
Hap differs from these examples in that Hap enzymatic activity requires
no modification of the protease domain subsequent to expression of the
precursor on the cell surface. Rather, processing serves to alter
localization of the passenger domain from the cell surface to the
extracellular environment. Release of Haps via a
predominantly intermolecular mechanism might therefore allow H. influenzae organisms to regulate the percentage of
Haps passenger domain associated with the cell surface by
modifying the expression level of precursor molecules. In this model,
one could imagine that during the initial stages of colonization,
bacteria might express a relatively low level of Hap on the cell
surface such that enough passenger domain is present to promote
adherence to epithelial structures and formation of microcolonies but
not enough to facilitate appreciable levels of autoproteolysis. Once
colonization reaches a stage at which available local binding sites are
saturated with dense colonies of organisms or a host immune response is elicited, bacteria might then increase Hap expression to levels that
promote processing, resulting in extracellular release of Haps. Such a transition might benefit the bacteria in a
variety of ways, for example, by removing an antigenic structure from the cell surface, by promoting disbursement of organisms from large
colonies and facilitating spread to new sites, and by allowing the
secreted protease domain to encounter host substrates involved in
subsequent stages of pathogenesis. Regulation of this transition might
be further influenced by inhibitors of Hap enzymatic activity, namely
secretory leukocyte protease inhibitor, which is present in normal
respiratory secretions and is increased in quantity in the setting of
inflammation (5).
In summary, the H. influenzae Hap autotransporter is a
member of the SA (chymotrypsin) clan of serine proteases with a
catalytic triad that consists of His98, Asp140,
and Ser243. These residues are conserved among a subset of
autotransporters that appear to constitute a distinct family within the
SA clan. Furthermore, Hap cleaves after large hydrophobic residues,
suggesting chymotrypsin-like substrate specificity. Autoproteolytic
release of the Haps passenger domain from the bacterial
cell surface occurs at least in part by intermolecular cleavage of one
precursor molecule by a neighboring molecule on the same cell. This
mechanism of autoproteolysis is consistent with the
density-dependent processing observed during controlled
expression of wild type Hap and suggests a novel mechanism for
regulation of bacterial adherence. Further investigation of Hap
autoproteolysis and Hap substrate specificity may provide clues as to
the ultimate purpose for release of the Hap passenger domain and
general insights into the diverse functions of serine proteases.
 |
ACKNOWLEDGEMENTS |
We thank Bruce Green for generous
contribution of plasmid pUC ECAT and anti-P4 monoclonal antibody
EPR5-2.1, Jerry Pinkner for valuable assistance in the purification of
Haps, and Thierry Rose, David Hendrixson, Gail Hardy, and
Enrico Di Cera for helpful discussions and critical reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported by an Established Investigator Award
from the American Heart Association (to J. W. S.), a research grant from the March of Dimes (to J. W. S.), United States
Public Health Service Grant AI17621 (to E. J. H.), and funds
from Wyeth-Lederle Vaccines.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Current address: Virus and Cell Biology Department, Merck & Co., Inc., West Point, PA 19486.
**
To whom corresponding should be addressed: Dept. of Pediatrics,
Washington University School of Medicine, 660 South Euclid Ave., Campus
Box 8208, St. Louis, MO 63110. Tel.: 314-286-2887; Fax: 314-286-2895;
E-mail: stgeme@borcim.wustl.edu.
Published, JBC Papers in Press, August 14, 2001, DOI 10.1074/jbc.M106913200
 |
ABBREVIATIONS |
The abbreviations used are:
PCR, polymerase chain reaction;
kb, kilobase(s);
PAGE, polyacrylamide gel
electrophoresis;
IPTG, isopropyl-1-thio- -D-galactopyranoside;
SPATEs, serine
protease autotransporters of the Enterobacteriaceae.
 |
REFERENCES |
| 1.
|
Henderson, I. R.,
Cappello, R.,
and Nataro, J. P.
(2000)
Trends Microbiol.
8,
529-532[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Henderson, I. R.,
and Nataro, J. P.
(2001)
Infect. Immun.
69,
1231-1243[Free Full Text]
|
| 3.
|
Turk, D. C.
(1984)
J. Med. Microbiol.
18,
1-16[Abstract/Free Full Text]
|
| 4.
|
St. Geme, J. W., III,
de la Morena, M. L.,
and Falkow, S.
(1994)
Mol. Microbiol.
14,
217-233[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Hendrixson, D. R.,
and St Geme, J. W., III
(1998)
Mol. Cell
2,
841-850[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Hendrixson, D.,
de la Morena, M. L.,
Stathopoulos, C.,
and St. Geme, J. W., III
(1997)
Mol. Microbiol.
26,
505-518[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Brunder, W.,
Schmidt, H.,
and Karch, H.
(1997)
Mol. Microbiol.
24,
767-778[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Eslava, C.,
Navarro-Garcia, F.,
Czeczulin, J. R.,
Henderson, I. R.,
Cravioto, A.,
and Nataro, J. P.
(1998)
Infect. Immun.
66,
3155-3163[Abstract/Free Full Text]
|
| 9.
|
Henderson, I. R.,
Czeczulin, J.,
Eslava, C.,
Noriega, F.,
and Nataro, J. P.
(1999)
Infect. Immun.
67,
5587-5596[Abstract/Free Full Text]
|
| 10.
|
Stathopoulos, C.,
Provence, D. L.,
and Curtiss, R., III
(1999)
Infect. Immun.
67,
772-781[Abstract/Free Full Text]
|
| 11.
|
Benjelloun-Touimi, Z.,
Sansonetti, P. J.,
and Parsot, C.
(1995)
Mol. Microbiol.
17,
123-135[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Stein, M.,
Kenny, B.,
Stein, M. A.,
and Finlay, B. B.
(1996)
J. Bacteriol.
178,
6546-6554[Abstract/Free Full Text]
|
| 13.
|
Al-Hasani, K.,
Henderson, I. R.,
Sakellaris, H.,
Rajakumar, K.,
Grant, T.,
Nataro, J. P.,
Robins-Browne, R.,
and Adler, B.
(2000)
Infect. Immun.
68,
2457-2463[Abstract/Free Full Text]
|
| 14.
|
Kilian, M.,
Mestecky, J.,
Kulhavy, R.,
Tomana, M.,
and Butler, W. T.
(1980)
J. Immunol.
124,
2596-2600[Abstract]
|
| 15.
|
Lin, L.,
Ayala, P.,
Larson, J.,
Mulks, M.,
Fukuda, M.,
Carlsson, S. R.,
Enns, C.,
and So, M.
(1997)
Mol. Microbiol.
24,
1083-1094[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Pohlner, J.,
Langenberg, U.,
Wolk, U.,
Beck, S. C.,
and Meyer, T. F.
(1995)
Mol. Microbiol.
17,
1073-1083[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Setlow, J. K.,
Brown, D. C.,
Boling, M. E.,
Mattingly, A.,
and Gordon, M. P.
(1968)
J. Bacteriol.
95,
546-558[Abstract/Free Full Text]
|
| 18.
|
Tomb, J. F.,
Barcak, G. J.,
Chandler, M. S.,
Redfield, R. J.,
and Smith, H. O.
(1989)
J. Bacteriol.
171,
3796-3802[Abstract/Free Full Text]
|
| 19.
|
Wittlin, S.,
Rosel, J.,
Hofmann, F.,
and Stover, D. R.
(1999)
Eur. J. Biochem.
265,
384-393[Medline]
[Order article via Infotrieve]
|
| 20.
|
Willson, P. J.,
Albritton, W. L.,
Slaney, L.,
and Setlow, J. K.
(1989)
Antimicrob. Agents Chemother.
33,
1627-1630[Abstract/Free Full Text]
|
| 21.
|
Anderson, P.,
Johnston, R. B., Jr.,
and Smith, D. H.
(1972)
J. Clin. Invest.
51,
31-38
|
| 22.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 23.
|
Herriott, R. M.,
Meyer, E. M.,
and Vogt, M.
(1970)
J. Bacteriol.
101,
517-524[Abstract/Free Full Text]
|
| 24.
|
Carlone, G. M.,
Thomas, M. L.,
Rumschlag, H. S.,
and Sottnek, F. O.
(1986)
J. Clin. Microbiol.
24,
330-332[Abstract/Free Full Text]
|
| 25.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Cope, L. D.,
Pelzel, S. E.,
Latimer, J. L.,
and Hansen, E. J.
(1990)
Infect. Immun.
58,
3312-3318[Abstract/Free Full Text]
|
| 27.
|
Setlow, J. K.,
Boling, M. E.,
Allison, D. P.,
and Beattie, K. L.
(1973)
J. Bacteriol.
115,
153-161[Abstract/Free Full Text]
|
| 28.
|
Matsudaira, P.
(1987)
J. Biol. Chem.
262,
10035-10038[Abstract/Free Full Text]
|
| 29.
|
Barrett, A. J.,
and Rawlings, N. D.
(1995)
Arch. Biochem. Biophys.
318,
247-250[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Rao, M. B.,
Tanksale, A. M.,
Ghatge, M. S.,
and Deshpande, V. V.
(1998)
Microbiol. Mol. Biol. Rev.
62,
597-635[Abstract/Free Full Text]
|
| 31.
|
Rawlings, N. D.,
and Barrett, A. J.
(1993)
Biochem. J.
290,
205-218
|
| 32.
|
Ohnishi, Y.,
Beppu, T.,
and Horinouchi, S.
(1997)
J. Biochem. (Tokyo)
121,
902-913[Abstract/Free Full Text]
|
| 33.
|
Lo, R. Y.,
Strathdee, C. A.,
Shewen, P. E.,
and Cooney, B. J.
(1991)
Infect. Immun.
59,
3398-3406[Abstract/Free Full Text]
|
| 34.
|
Krem, M. M.,
and Di Cera, E.
(2001)
EMBO J.
20,
3036-3045[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Gomis-Ruth, F. X.,
Gomez, M.,
Bode, W.,
Huber, R.,
and Aviles, F. X.
(1995)
EMBO J.
14,
4387-4394[Medline]
[Order article via Infotrieve]
|
| 36.
|
Read, R. J.,
and James, M. N.
(1988)
J. Mol. Biol.
200,
523-551[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Benjelloun-Touimi, Z.,
Tahar, M. S.,
Montecucco, C.,
Sansonetti, P. J.,
and Parsot, C.
(1998)
Microbiology
144,
1815-1822[Abstract/Free Full Text]
|
| 38.
|
Plaut, A. G.,
and Bachovchin, W. W.
(1994)
Methods Enzymol.
244,
137-151[Medline]
[Order article via Infotrieve]
|
| 39.
|
Kasche, V.,
Lummer, K.,
Nurk, A.,
Piotraschke, E.,
Rieks, A.,
Stoeva, S.,
and Voelter, W.
(1999)
Biochim. Biophys. Acta
1433,
76-86[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Michetti, M.,
Salamino, F.,
Tedesco, I.,
Averna, M.,
Minafra, R.,
Melloni, E.,
and Pontremoli, S.
(1996)
FEBS Lett.
392,
11-15[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Weinheimer, S. P.,
McCann, P. J., 3rd,
O'Boyle, D. R., 2nd,
Stevens, J. T.,
Boyd, B. A.,
Drier, D. A.,
Yamanaka, G. A.,
DiIanni, C. L.,
Deckman, I. C.,
and Cordingley, M. G.
(1993)
J. Virol.
67,
5813-5822[Abstract/Free Full Text]
|
| 42.
|
Guan, C.,
Cui, T.,
Rao, V.,
Liao, W.,
Benner, J.,
Lin, C. L.,
and Comb, D.
(1996)
J. Biol. Chem.
271,
1732-1737[Abstract/Free Full Text]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y.-h. Hu, C.-s. Liu, J.-h. Hou, and L. Sun
Identification, Characterization, and Molecular Application of a Virulence-Associated Autotransporter from a Pathogenic Pseudomonas fluorescens Strain
Appl. Envir. Microbiol.,
July 1, 2009;
75(13):
4333 - 4340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-E. Charbonneau, J. Janvore, and M. Mourez
Autoprocessing of the Escherichia coli AIDA-I Autotransporter: A NEW MECHANISM INVOLVING ACIDIC RESIDUES IN THE JUNCTION REGION
J. Biol. Chem.,
June 19, 2009;
284(25):
17340 - 17351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Choy, M. M. Kelley, T. L. Chen, A. K. Moller, J. Matsunaga, and D. A. Haake
Physiological Osmotic Induction of Leptospira interrogans Adhesion: LigA and LigB Bind Extracellular Matrix Proteins and Fibrinogen
Infect. Immun.,
May 1, 2007;
75(5):
2441 - 2450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Lipski, C. Akimana, J. M. Timpe, R. M. Wooten, and E. R. Lafontaine
The Moraxella catarrhalis Autotransporter McaP Is a Conserved Surface Protein That Mediates Adherence to Human Epithelial Cells through Its N-Terminal Passenger Domain
Infect. Immun.,
January 1, 2007;
75(1):
314 - 324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-E. Charbonneau, F. Berthiaume, and M. Mourez
Proteolytic Processing Is Not Essential for Multiple Functions of the Escherichia coli Autotransporter Adhesin Involved in Diffuse Adherence (AIDA-I)
J. Bacteriol.,
December 15, 2006;
188(24):
8504 - 8512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Webster, S. Wu, G. Gomez, M. Apicella, A. G. Plaut, and J. W. St. Geme III
Distribution of Bacterial Proteins in Biofilms Formed by Non-typeable Haemophilus influenzae
J. Histochem. Cytochem.,
July 1, 2006;
54(7):
829 - 842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Parham, S. J. Pollard, M. Desvaux, A. Scott-Tucker, C. Liu, A. Fivian, and I. R. Henderson
Distribution of the Serine Protease Autotransporters of the Enterobacteriaceae among Extraintestinal Clinical Isolates of Escherichia coli
J. Clin. Microbiol.,
August 1, 2005;
43(8):
4076 - 4082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. R. Henderson, F. Navarro-Garcia, M. Desvaux, R. C. Fernandez, and D. Ala'Aldeen
Type V Protein Secretion Pathway: the Autotransporter Story
Microbiol. Mol. Biol. Rev.,
December 1, 2004;
68(4):
692 - 744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kostakioti and C. Stathopoulos
Functional Analysis of the Tsh Autotransporter from an Avian Pathogenic Escherichia coli Strain
Infect. Immun.,
October 1, 2004;
72(10):
5548 - 5554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Patel, J. Dotson, K. P. Allen, and J. M. Fleckenstein
Identification and Molecular Characterization of EatA, an Autotransporter Protein of Enterotoxigenic Escherichia coli
Infect. Immun.,
March 1, 2004;
72(3):
1786 - 1794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Dutta, B. Q. Sui, and J. P. Nataro
Structure-Function Analysis of the Enteroaggregative Escherichia coli Plasmid-encoded Toxin Autotransporter Using Scanning Linker Mutagenesis
J. Biol. Chem.,
October 10, 2003;
278(41):
39912 - 39920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Coutte, S. Alonso, N. Reveneau, E. Willery, B. Quatannens, C. Locht, and F. Jacob-Dubuisson
Role of Adhesin Release for Mucosal Colonization by a Bacterial Pathogen
J. Exp. Med.,
March 17, 2003;
197(6):
735 - 742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Dutta, R. Cappello, F. Navarro-Garcia, and J. P. Nataro
Functional Comparison of Serine Protease Autotransporters of Enterobacteriaceae
Infect. Immun.,
December 1, 2002;
70(12):
7105 - 7113.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|